UNSPSC 51373445: Codeine/ipecac/phenylephrine/potassium/promethazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373445 Codeine/ipecac/phenylephrine/potassium/promethazine is a Commodity code, but recent state and local solicitations tagged to it show minimal alignment with the code's nominal scope. The sole recent opportunity directly matching the code's pharmaceutical intent is the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products, which seeks manufacturers to supply a broad range of medications through authorized wholesalers to participating state and local government facilities across Minnesota, Oregon, and other member jurisdictions. A second opportunity—Seminole County, Florida's IFB for naloxone and drug deactivation systems—addresses opioid-response supplies rather than the specific drug compounds named in the code. State and local governments buying under this code appear to procure pharmaceutical products through cooperative purchasing vehicles and direct-buy IFBs, typically requiring FDA compliance, cGMP certification, Drug Supply Chain Security Act (DSCSA) adherence, and delivery to specified public health or community health facilities. The issuing bodies are primarily state departments administering cooperative purchasing programs and county health departments.

MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, posted the most significant recent opportunity on January 20, 2026, with an RFP due March 26, 2026, seeking manufacturers to supply identified pharmaceutical products with specific National Drug Codes through three authorized wholesalers, with awarded vendors effective July 1, 2026. Evaluation weights pricing competitiveness at 75 percent, administrative compliance at 10 percent, EDI capability at 5 percent, and administrative fee agreement at 5 percent. Vendors must maintain contractual relationships with at least two of the three authorized wholesalers and carry commercial general liability of $5 million per occurrence, professional liability of $2 million, and network security and privacy liability of $2 million. Seminole County's June 30, 2026 IFB (due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, requiring E-Verify compliance, drug-free workplace certification, and a two-year initial term with one-year renewal option. The code shows limited recent activity specific to its nominal pharmaceutical scope; cooperative purchasing and opioid-response procurement dominate current state and local solicitations.